Pharmacoeconomics and policy decisions: The Australian Health Care System

David Henry, Ruth Lopert

Research output: Contribution to journalReview articleResearchpeer-review

6 Citations (Scopus)

Abstract

This paper provides an overview of the use of pharmacoeconomic analysis in the process that governs drug reimbursement decisions in Australia. It discusses the methods by which drugs are evaluated, both clinically and economically, and the means by which these 2 facets are amalgamated; the types of pharmacoeconomic data submitted in support of requests for reimbursement; the methods and standards used to assess these data; some of the more commonly encountered flaws in the data submitted; and how the different types of data influence reimbursement decisions.

Original languageEnglish
Pages (from-to)909-915
Number of pages7
JournalClinical Therapeutics
Volume21
Issue number5
DOIs
Publication statusPublished - 1999
Externally publishedYes

Fingerprint

Pharmaceutical Economics
Delivery of Health Care
Pharmaceutical Preparations

Cite this

@article{27fd4073103747a1973edb911a76148f,
title = "Pharmacoeconomics and policy decisions: The Australian Health Care System",
abstract = "This paper provides an overview of the use of pharmacoeconomic analysis in the process that governs drug reimbursement decisions in Australia. It discusses the methods by which drugs are evaluated, both clinically and economically, and the means by which these 2 facets are amalgamated; the types of pharmacoeconomic data submitted in support of requests for reimbursement; the methods and standards used to assess these data; some of the more commonly encountered flaws in the data submitted; and how the different types of data influence reimbursement decisions.",
author = "David Henry and Ruth Lopert",
year = "1999",
doi = "10.1016/S0149-2918(99)80012-5",
language = "English",
volume = "21",
pages = "909--915",
journal = "Clinical Therapeutics",
issn = "0149-2918",
publisher = "Excerpta Medica",
number = "5",

}

Pharmacoeconomics and policy decisions : The Australian Health Care System. / Henry, David; Lopert, Ruth.

In: Clinical Therapeutics, Vol. 21, No. 5, 1999, p. 909-915.

Research output: Contribution to journalReview articleResearchpeer-review

TY - JOUR

T1 - Pharmacoeconomics and policy decisions

T2 - The Australian Health Care System

AU - Henry, David

AU - Lopert, Ruth

PY - 1999

Y1 - 1999

N2 - This paper provides an overview of the use of pharmacoeconomic analysis in the process that governs drug reimbursement decisions in Australia. It discusses the methods by which drugs are evaluated, both clinically and economically, and the means by which these 2 facets are amalgamated; the types of pharmacoeconomic data submitted in support of requests for reimbursement; the methods and standards used to assess these data; some of the more commonly encountered flaws in the data submitted; and how the different types of data influence reimbursement decisions.

AB - This paper provides an overview of the use of pharmacoeconomic analysis in the process that governs drug reimbursement decisions in Australia. It discusses the methods by which drugs are evaluated, both clinically and economically, and the means by which these 2 facets are amalgamated; the types of pharmacoeconomic data submitted in support of requests for reimbursement; the methods and standards used to assess these data; some of the more commonly encountered flaws in the data submitted; and how the different types of data influence reimbursement decisions.

UR - http://www.scopus.com/inward/record.url?scp=0033005669&partnerID=8YFLogxK

U2 - 10.1016/S0149-2918(99)80012-5

DO - 10.1016/S0149-2918(99)80012-5

M3 - Review article

VL - 21

SP - 909

EP - 915

JO - Clinical Therapeutics

JF - Clinical Therapeutics

SN - 0149-2918

IS - 5

ER -